---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-026905"
form_type: "8-K"
ticker: "AVTR"
cik: "0001722482"
company_name: "Avantor, Inc."
filed_at: "2026-04-23T23:59:59+00:00"
generated_at: "2026-05-15T04:35:27.368194+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Avantor names Ludovic Brellier EVP Bioscience & Medtech Products; Gourdier to depart by Dec 2026

## Summary
- Ludovic Brellier appointed EVP, Bioscience & Medtech Products and Chief Transformation Officer effective May 1, 2026.
- Brellier joins from Danaher, where he was President of Cytiva’s Hardware Solutions; will lead Revival Management Office.
- Current EVP Benoit Gourdier will transition to a support role and depart Avantor no later than December 31, 2026.
- Brellier to oversee BMP business growth, operational performance, and enterprise transformation initiatives.

## SEC filing metadata
- accession: 0001628280-26-026905
- form_type: 8-K
- ticker: AVTR
- cik: 0001722482
- company_name: Avantor, Inc.
- filed_at: 2026-04-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1722482/000162828026026905/0001628280-26-026905-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1722482/000162828026026905/avtr-20260417.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-026905
- JSON: https://secwatch.observer/filing/0001628280-26-026905.json
- Plain text: https://secwatch.observer/filing/0001628280-26-026905.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.